- Home
- GMS vs LIVN Comparison
GMS vs LIVN Comparison
Compare GMS & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMS
- LIVN
- Stock Information
- Founded
- GMS 1971
- LIVN 1987
- Country
- GMS United States
- LIVN United Kingdom
- Employees
- GMS N/A
- LIVN N/A
- Industry
- GMS
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GMS
- LIVN Health Care
- Exchange
- GMS Nasdaq
- LIVN Nasdaq
- Market Cap
- GMS N/A
- LIVN 2.1B
- IPO Year
- GMS 2016
- LIVN 1993
- Fundamental
- Price
- GMS $75.53
- LIVN $44.07
- Analyst Decision
- GMS Hold
- LIVN Buy
- Analyst Count
- GMS 7
- LIVN 7
- Target Price
- GMS $80.57
- LIVN $58.57
- AVG Volume (30 Days)
- GMS 295.3K
- LIVN 851.4K
- Earning Date
- GMS 06-20-2025
- LIVN 05-07-2025
- Dividend Yield
- GMS N/A
- LIVN N/A
- EPS Growth
- GMS N/A
- LIVN N/A
- EPS
- GMS 3.66
- LIVN N/A
- Revenue
- GMS $5,592,971,000.00
- LIVN $1,275,437,000.00
- Revenue This Year
- GMS $0.80
- LIVN $5.79
- Revenue Next Year
- GMS $0.63
- LIVN $5.51
- P/E Ratio
- GMS $19.96
- LIVN N/A
- Revenue Growth
- GMS 3.71
- LIVN 7.63
- 52 Week Low
- GMS $65.77
- LIVN $32.48
- 52 Week High
- GMS $105.54
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- GMS 57.18
- LIVN 70.21
- Support Level
- GMS $71.64
- LIVN $35.00
- Resistance Level
- GMS $75.34
- LIVN $37.95
- Average True Range (ATR)
- GMS 1.85
- LIVN 1.29
- MACD
- GMS 0.37
- LIVN 0.93
- Stochastic Oscillator
- GMS 85.08
- LIVN 94.84
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.